In patients with melanoma, B cells express several angiogenic factors, such as sphingosine-1-phosphate receptor 1 (S1PR1), matrix metallopeptidase 9 (MMP9), hypoxia-inducible factor 1-alpha (HIF1a), and VEGF. This evidence concerns the gene MMP9 and melanoma.